Nvestor

Developer of an artificial intelligence-based drug discovery platform designed to maximize the efficiency of new drug development. The company's platform advances the treatment of rare and intractable diseases through the integration of artificial intelligence and collective intelligence and specializes in genome data analysis, biomarker prediction, molecule selection, and optimization, enabling clinicians to realize precision medicine by designing small molecules for new drugs.

StradVision, Inc. specializes in developing perception algorithms for advanced driver assistance systems (ADAS) and autonomous vehicles. Founded in 2014 and headquartered in San Jose, California, with additional offices in South Korea, Germany, India, Japan, and China, the company offers various products including SVNet External for external vehicle perception and SVNet Internal for monitoring driver and passenger status. StradVision's technology utilizes artificial intelligence and deep learning to enhance vehicle safety features such as lane detection, object recognition, and real-time environmental analysis. The firm also provides an Auto Labeling Tool for automatic annotation of key objects and road elements. With a strong emphasis on innovation, StradVision holds over 60 patents and has more than 150 pending, positioning itself as a significant player in the automotive technology sector, particularly in the transition towards autonomous driving solutions.

Developer of a reward points application designed to offer cash benefits to customers. The company's application offers to earn points for purchase from offline marts to online shopping malls by registering their purchase information and also provides marketing services, enabling customers to have rewards points on their purchases.